Heart stent patients: could a tailored blood thinner dose reduce risks?
NCT ID NCT07582835
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study looks for the safest and most effective dose of blood thinners (P2Y12 inhibitors) for people who have had a heart stent placed. About 355 participants will try different doses to find one that keeps blood clotting at a healthy level—not too high (which can cause clots) and not too low (which can cause bleeding). The goal is to personalize treatment to improve long-term outcomes after a stent procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istituto Cardiocentro Ticino
RECRUITINGLugano, Ch/ti, 6900, Switzerland
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.